Séverine Schneider

Action of Ciprofibrate in Type IIB Hyperlipoproteinemia: Modulation of the Atherogenic Lipoprotein Phenotype and Stimulation of High-Density Lipoprotein-Mediated Cellular Cholesterol Efflux

Maryse Guérin, Wilfried Le Goff, Éric Frisdal et al. · The Journal of Clinical Endocrinology & Metabolism · 2003 · 51 citations

A bifunctional-biased mu-opioid agonist–neuropeptide FF receptor antagonist as analgesic with improved acute and chronic side effects

Armand Drieu la Rochelle, Karel Guillemyn, Maria Dumitrascuta et al. · Pain · 2018 · 42 citations

Development of a Peptidomimetic Antagonist of Neuropeptide FF Receptors for the Prevention of Opioid-Induced Hyperalgesia

Frédéric Bihel, Jean‐Paul Humbert, Séverine Schneider et al. · ACS Chemical Neuroscience · 2015 · 26 citations

Neuropeptides, Pain Medicine, Molecular Pain +18

RF313, an orally bioavailable neuropeptide FF receptor antagonist, opposes effects of RF-amide-related peptide-3 and opioid-induced hyperalgesia in rodents

Khadija Elhabazi, Jean‐Paul Humbert, Isabelle Bertin et al. · Neuropharmacology · 2017 · 24 citations

Pain Medicine, Medicine, Neuropeptide Receptor +10

Effects of systematic N-terminus deletions and benzoylations of endogenous RF-amide peptides on NPFF1R, NPFF2R, GPR10, GPR54 and GPR103

Laurent Rouméas, Jean‐Paul Humbert, Séverine Schneider et al. · Peptides · 2015 · 19 citations

Medicinal Chemistry, Biochemistry, Natural Sciences +7